Published in J Pathol Clin Res on January 13, 2017
Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med (1998) 25.41
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science (2006) 24.54
What's wrong with Bonferroni adjustments. BMJ (1998) 19.89
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer. N Engl J Med (2016) 8.53
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration. PLoS Med (2012) 3.62
REporting recommendations for tumor MARKer prognostic studies (REMARK). Nat Clin Pract Oncol (2005) 2.82
A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers. J Clin Oncol (2008) 2.43
Sex steroid hormone receptors in human thymoma. J Clin Endocrinol Metab (2003) 1.38
Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in human breast cancer. Virchows Arch A Pathol Anat Histopathol (1986) 1.35
A new approach to the validation of tissue microarrays. J Pathol (2006) 1.23
Adjusting for multiple testing in studies is less important than other concerns. BMJ (1999) 1.15
Mining tissue microarray data to uncover combinations of biomarker expression patterns that improve intermediate staging and grading of clear cell renal cell cancer. Clin Cancer Res (2009) 1.06
Next-generation tissue microarray (ngTMA) increases the quality of biomarker studies: an example using CD3, CD8, and CD45RO in the tumor microenvironment of six different solid tumor types. J Transl Med (2013) 1.04
Guidelines and considerations for conducting experiments using tissue microarrays. Histopathology (2013) 1.02
Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency. Int J Cancer (2013) 1.02
Virtual microscopy as an enabler of automated/quantitative assessment of protein expression in TMAs. Histochem Cell Biol (2008) 1.01
A next-generation tissue microarray (ngTMA) protocol for biomarker studies. J Vis Exp (2014) 1.00
Digital pathology and image analysis in tissue biomarker research. Methods (2014) 0.99
Quantification of protein expression in cells and cellular subcompartments on immunohistochemical sections using a computer supported image analysis system. Histol Histopathol (2013) 0.98
Prognostic significance of pathologic complete response and Ki67 expression after neoadjuvant chemotherapy in breast cancer. Breast Cancer (2013) 0.94
Expression of the Pluripotency Transcription Factor OCT4 in the Normal and Aberrant Mammary Gland. Front Oncol (2013) 0.88
Digital image analysis outperforms manual biomarker assessment in breast cancer. Mod Pathol (2016) 0.86
VE1 immunohistochemistry predicts BRAF V600E mutation status and clinical outcome in colorectal cancer. Oncotarget (2015) 0.85
Quantification of tumour budding, lymphatic vessel density and invasion through image analysis in colorectal cancer. J Transl Med (2014) 0.85
Involvement of CDX2 in the cross talk between TNF-α and Wnt signaling pathway in the colon cancer cell line Caco-2. Carcinogenesis (2014) 0.84
Automated tumor analysis for molecular profiling in lung cancer. Oncotarget (2015) 0.83
Continuous tissue microarray based identification of cancers with homogeneous target expression for successful targeted therapy in clinical routine practice. Genes Chromosomes Cancer (2013) 0.82
Applications of pathology-assisted image analysis of immunohistochemistry-based biomarkers in oncology. Vet Pathol (2013) 0.81
Image analysis of immunohistochemistry is superior to visual scoring as shown for patient outcome of esophageal adenocarcinoma. Histochem Cell Biol (2014) 0.81
FGFR1 Amplification Is Often Homogeneous and Strongly Linked to the Squamous Cell Carcinoma Subtype in Esophageal Carcinoma. PLoS One (2015) 0.80
Image-guided Coring for Large-scale Studies in Molecular Pathology. Appl Immunohistochem Mol Morphol (2016) 0.79
Mismatch repair gene defects in sporadic colorectal cancer enhance immune surveillance. Oncotarget (2015) 0.79
Comparison between Ki67 labeling index determined using image analysis software with virtual slide system and that determined visually in breast cancer. Breast Cancer (2015) 0.78
CDX2: Linking Cell and Patient Fates in Colon Cancer. Cell Stem Cell (2016) 0.77
Tissue Microarrays. Methods Mol Biol (2016) 0.77
Pathological examination of breast cancer biomarkers: current status in Japan. Breast Cancer (2014) 0.77
PTEN mRNA detection by chromogenic, RNA in situ technologies: a reliable alternative to PTEN immunohistochemistry. Hum Pathol (2015) 0.77
Digital immunohistochemistry wizard: image analysis-assisted stereology tool to produce reference data set for calibration and quality control. Diagn Pathol (2014) 0.76